Evaluation of Insulin Resistance Indices in Type 2 Diabetic Patients Treated with Different Anti-Diabetic Drugs
Open Access
- 1 January 2016
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Endocrine and Metabolic Diseases
- Vol. 06 (02), 95-101
- https://doi.org/10.4236/ojemd.2016.62013
Abstract
Clinically, determination of insulin resistance is important for diabetic patients. We evaluated the relationship among 20/(fasting C-peptide × fasting plasma glucose), HOMA-IR and QUICKI indices in type 2 diabetic patients. The study included 40 patients with type 2 diabetes. Patients divided into three groups based on their medication: metformin, metformin + glibenclamide and metformin + glitazone. Fasting blood sugar, and lipid profile were measured by enzymatic method, serum insulin, and C-peptide were measured by ELISA method. Insulin resistance was calculated by using of 20/(fasting C-peptide × fasting plasma glucose), HOMA-IR and QUICKI indices. There was no significant relationship between 20/(fasting C-peptide × fasting plasma glucose) index and other parameters in all studied groups except QUICKI in metformin group showed a significant correlation with 20/(fasting C-peptide × fasting plasma glucose) index (r = 0.56 and p = 0.03). There was a significant correlation between HOMA-IR and QUICKI indices in all studied groups. There was no significant relationship between 20/(fasting C-peptide × fasting plasma glucose) index with other clinical parameters. On the other hand, our data strongly suggested a significant correlation between HOMA-IR and QUICKI indices in studied subjects with type 2 diabetes.Keywords
This publication has 13 references indexed in Scilit:
- Determinants of Health-Promoting Behaviors among Type 2 Diabetic Patients: Voice of IranOpen Journal of Endocrine and Metabolic Diseases, 2014
- 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary reportCardiovascular Diabetology, 2013
- Selection of the appropriate method for the assessment of insulin resistanceBMC Medical Research Methodology, 2011
- Diabetes mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types*Diabetic Medicine, 2011
- Assessment of Insulin Resistance and Insulin Growth Factor-1 in Egyptian Patients with Chronic Hepatitis COpen Journal of Endocrine and Metabolic Diseases, 2011
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 DiabetesDiabetes Care, 2008
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usageAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in KoreaMetabolism, 2005
- Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.JCI Insight, 1986
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985